X

Trial Profile

Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected Adults

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 10 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Agatolimod (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate; Pneumococcal vaccine
Indications Pneumococcal infections
Focus Adverse reactions; Pharmacodynamics
Acronyms ITAP

Most Recent Events

26 May 2010 Results published in Clinical Infectious Diseases.
13 Sep 2009 Results reported at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy.
20 Jan 2009 Patient numbers amended from 94 to 97 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com